These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 7778055)
41. Characterization of Bay U 3405, a novel thromboxane A2/endoperoxide receptor antagonist. Perzborn E; Fiedler VB; Seuter F; Stasch JP; Weber H; Sander E; Böshagen H; Rosentreter U Stroke; 1990 Dec; 21(12 Suppl):IV143-5. PubMed ID: 2148034 [TBL] [Abstract][Full Text] [Related]
42. Effect of picotamide on platelet aggregation and on thromboxane A2 production in vivo. Minuz P; Lechi C; Arosio E; Guzzo P; Zannoni M; Lauciello C; Lechi A Thromb Haemost; 1991 Mar; 65(3):312-6. PubMed ID: 2048055 [TBL] [Abstract][Full Text] [Related]
43. Pharmacological characterization of 2NTX-99 [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a potential antiatherothrombotic agent with antithromboxane and nitric oxide donor activity in platelet and vascular preparations. Buccellati C; Sala A; Rossoni G; Capra V; Rovati GE; Di Gennaro A; Folco G; Colli S; Casagrande C J Pharmacol Exp Ther; 2006 May; 317(2):830-7. PubMed ID: 16399881 [TBL] [Abstract][Full Text] [Related]
44. Competitive antagonism at thromboxane receptors in human platelets. Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580 [TBL] [Abstract][Full Text] [Related]
45. Effects of some antineoplastic drugs (vincristine, doxorubicin and epirubicin) on human platelet aggregation. Matera C; Falzarano C; Vacca C; Falciani M; Rossi F J Med; 1994; 25(1-2):2-16. PubMed ID: 7930957 [TBL] [Abstract][Full Text] [Related]
46. The in vivo antiplatelet effects of thromboxane A2 synthase inhibitors are potentiated by simultaneous thromboxane A2/prostaglandin H2 receptor blockade. Golino P; Ambrosio G; Gresele P; Pascucci I; Ragni M; Russolillo E; Leproux GB; Chiariello M J Pharmacol Exp Ther; 1993 Aug; 266(2):511-7. PubMed ID: 8355187 [TBL] [Abstract][Full Text] [Related]
47. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate. Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011 [TBL] [Abstract][Full Text] [Related]
48. Synthesis and the Evaluations in vitro Antiplatelet Aggregation Activities of 4-Ethoxyisophthalamides. Liu XJ; Shi TE; Wang X; Wei TT; Meng X Cardiovasc Hematol Agents Med Chem; 2015; 13(2):124-8. PubMed ID: 26695422 [TBL] [Abstract][Full Text] [Related]
49. Pharmacological profile of G619, a new platelet aggregation inhibitor. Yue TL; Smith EF; Ohlstein EH; Sulpizio A; Slivjak MJ; Rabinovici R; Sellers TS; Lynch KM; Poyser R; Feuerstein G Thromb Res; 1992 May; 66(4):331-47. PubMed ID: 1412200 [TBL] [Abstract][Full Text] [Related]
50. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF. Porta C; Maiolo A; Tua A; Grignani G Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928 [TBL] [Abstract][Full Text] [Related]
51. Inhibition of platelet aggregation by some flavonoids. Tzeng SH; Ko WC; Ko FN; Teng CM Thromb Res; 1991 Oct; 64(1):91-100. PubMed ID: 1776142 [TBL] [Abstract][Full Text] [Related]
52. Antiplatelet effect of butylidenephthalide. Teng CM; Chen WY; Ko WC; Ouyang CH Biochim Biophys Acta; 1987 Jun; 924(3):375-82. PubMed ID: 3109495 [TBL] [Abstract][Full Text] [Related]
53. Effect of low doses of ethanol on platelet function in long-life abstainers and moderate-wine drinkers. Miceli M; Alberti L; Bennardini F; Di Simplicio P; Seghieri G; Rao GH; Franconi F Life Sci; 2003 Aug; 73(12):1557-66. PubMed ID: 12865095 [TBL] [Abstract][Full Text] [Related]
54. Modulatory effect of 8-iso-PGE2 on platelets. Kobzar G; Mardla V; Järving I; Samel N; Lõhmus M Gen Pharmacol; 1997 Feb; 28(2):317-21. PubMed ID: 9013211 [TBL] [Abstract][Full Text] [Related]
55. The inhibitory effect of cinchonine on human platelet aggregation due to blockade of calcium influx. Shah BH; Nawaz Z; Virani SS; Ali IQ; Saeed SA; Gilani AH Biochem Pharmacol; 1998 Oct; 56(8):955-60. PubMed ID: 9776305 [TBL] [Abstract][Full Text] [Related]
56. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro. Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909 [TBL] [Abstract][Full Text] [Related]
57. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide. Rendu F; Bachelot C; Molle D; Caen J; Guez D J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063 [TBL] [Abstract][Full Text] [Related]
58. Phenothiazines inhibit collagen-induced thromboxane B2 synthesis and increase forskolin anti-aggregating effects in human platelets. Anfossi G; Massucco P; Mularoni E; Cavalot F; Burzacca S; Mattiello L; Trovati M Gen Pharmacol; 1991; 22(5):773-8. PubMed ID: 1684769 [TBL] [Abstract][Full Text] [Related]
59. Effects of Policosanol on platelet aggregation in rats. Arruzazabala ML; Carbajal D; Mas R; Garcia M; Fraga V Thromb Res; 1993 Feb; 69(3):321-7. PubMed ID: 8475481 [TBL] [Abstract][Full Text] [Related]
60. Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil. Petroni A; Blasevich M; Salami M; Papini N; Montedoro GF; Galli C Thromb Res; 1995 Apr; 78(2):151-60. PubMed ID: 7482432 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]